Research
Loss of confidence in commercial antibody validation threatens biomedical research integrity
Nature ·
The Brief
- A research article in the Nature-family journal Communications Biology addresses confidence in how commercial antibodies are validated.
- The headline states that this loss of confidence threatens biomedical research integrity.
- Source information is limited to the headline and feed listing, with no summary available.
Why it matters
Commercial antibodies are widely used in biomedical experiments, so weak validation can affect whether published results can be reproduced and trusted.
Who’s affected
- biomedical researchers
- laboratories that rely on commercially supplied antibodies
- #antibodies
- #research integrity
- #reproducibility
- #biomedical research
- #assay validation